Toward Increased Reliability, Transparency, and Accessibility in Cross-linking Mass Spectrometry.


Journal

Structure (London, England : 1993)
ISSN: 1878-4186
Titre abrégé: Structure
Pays: United States
ID NLM: 101087697

Informations de publication

Date de publication:
03 11 2020
Historique:
received: 26 06 2020
revised: 02 09 2020
accepted: 24 09 2020
pubmed: 17 10 2020
medline: 15 10 2021
entrez: 16 10 2020
Statut: ppublish

Résumé

Cross-linking mass spectrometry (MS) has substantially matured as a method over the past 2 decades through parallel development in multiple labs, demonstrating its applicability to protein structure determination, conformation analysis, and mapping protein interactions in complex mixtures. Cross-linking MS has become a much-appreciated and routinely applied tool, especially in structural biology. Therefore, it is timely that the community commits to the development of methodological and reporting standards. This white paper builds on an open process comprising a number of events at community conferences since 2015 and identifies aspects of Cross-linking MS for which guidelines should be developed as part of a Cross-linking MS standards initiative.

Identifiants

pubmed: 33065067
pii: S0969-2126(20)30336-1
doi: 10.1016/j.str.2020.09.011
pii:
doi:

Substances chimiques

Cross-Linking Reagents 0
Proteins 0

Types de publication

Congress Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1259-1268

Subventions

Organisme : Wellcome Trust
ID : 103139
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203149
Pays : United Kingdom

Informations de copyright

Copyright © 2020.

Auteurs

Alexander Leitner (A)

Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, 8093 Zurich, Switzerland. Electronic address: leitner@imsb.biol.ethz.ch.

Alexandre M J J Bonvin (AMJJ)

Bijvoet Centre for Biomolecular Research, Faculty of Science-Chemistry, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands.

Christoph H Borchers (CH)

University of Victoria-Genome British Columbia Proteomics Centre, University of Victoria, Victoria, BC V8Z 7X8, Canada; Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC V8P 5C2, Canada; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada; Gerald Bronfman Department of Oncology, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada; Center for Computational and Data-Intensive Science and Engineering, Skolkovo Institute of Science and Technology, Moscow 121205, Russia.

Robert J Chalkley (RJ)

Department of Pharmaceutical Chemistry, University of California San Francisco, 600 16th Street, Genentech Hall, Suite N472A, San Francisco, CA 94143-2240, USA.

Julia Chamot-Rooke (J)

Institut Pasteur-CNRS USR 2000, Mass Spectrometry for Biology Unit, 28, Rue du Dr. Roux, 75 015 Paris, France.

Colin W Combe (CW)

Wellcome Centre for Cell Biology, School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3BF, Scotland, UK.

Jürgen Cox (J)

Computational Systems Biochemistry Research Group, Max-Planck Institute of Biochemistry, Am Klopferspitz 18, 82152 Martinsried, Germany.

Meng-Qiu Dong (MQ)

National Institute of Biological Sciences, Beijing, Beijing 102206, China.

Lutz Fischer (L)

Bioanalytics, Institute of Biotechnology, Technische Universität Berlin, 13355 Berlin, Germany.

Michael Götze (M)

Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, 8093 Zurich, Switzerland.

Fabio C Gozzo (FC)

Institute of Chemistry, University of Campinas, Campinas - SP 13083-970, Brazil.

Albert J R Heck (AJR)

Biomolecular Mass Spectrometry and Proteomics, Bijvoet Centre for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CH Utrecht, The Netherlands; Netherlands Proteomics Centre, Utrecht University, 3584 CH Utrecht, The Netherlands.

Michael R Hoopmann (MR)

Institute for Systems Biology, 401 Terry Avenue North, Seattle, WA 98109, USA.

Lan Huang (L)

Department of Physiology & Biophysics, University of California, Irvine, Irvine, CA 92697, USA.

Yasushi Ishihama (Y)

Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan.

Andrew R Jones (AR)

Institute of Integrative Biology, University of Liverpool, Biosciences Building, Crown Street, Liverpool L69 7ZB, UK.

Nir Kalisman (N)

Department of Biological Chemistry, Institute of Life Sciences, Hebrew University of Jerusalem, Jerusalem 91904, Israel.

Oliver Kohlbacher (O)

Department of Computer Science, University of Tübingen, Sand 14, 72076 Tübingen, Germany; Institute for Bioinformatics and Medical Informatics, University of Tübingen, Sand 14, 72076 Tübingen, Germany; Institute for Translational Bioinformatics, University Hospital Tübingen, Hoppe-Seyler-Strasse 9, 72076 Tübingen, Germany; Biomolecular Interactions, Max Planck Institute for Developmental Biology, Max-Planck-Ring 5, 72076 Tübingen, Germany.

Karl Mechtler (K)

Research Institute of Molecular Pathology, Campus-Vienna-Biocenter 1, 1030 Vienna, Austria.

Robert L Moritz (RL)

Institute for Systems Biology, 401 Terry Avenue North, Seattle, WA 98109, USA.

Eugen Netz (E)

Department of Computer Science, University of Tübingen, Sand 14, 72076 Tübingen, Germany; Biomolecular Interactions, Max Planck Institute for Developmental Biology, Max-Planck-Ring 5, 72076 Tübingen, Germany.

Petr Novak (P)

Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University, Institute of Microbiology, The Czech Academy of Sciences, 252 50 Vestec, Czech Republic.

Evgeniy Petrotchenko (E)

Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada; Center for Computational and Data-Intensive Science and Engineering, Skolkovo Institute of Science and Technology, Moscow 121205, Russia.

Andrej Sali (A)

Department of Bioengineering and Therapeutic Sciences, Department of Pharmaceutical Chemistry, California Institute for Quantitative Biosciences, University of California, San Francisco, 1700 4th Street, San Francisco, CA 94143, USA.

Richard A Scheltema (RA)

Biomolecular Mass Spectrometry and Proteomics, Bijvoet Centre for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CH Utrecht, The Netherlands; Netherlands Proteomics Centre, Utrecht University, 3584 CH Utrecht, The Netherlands.

Carla Schmidt (C)

Interdisciplinary Research Center HALOmem, Institute for Biochemistry and Biotechnology, Martin Luther University Halle-Wittenberg, Kurt-Mothes-Strasse 3a, 06120 Halle/Saale, Germany.

David Schriemer (D)

Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB T2N 4N1, Canada; Robson DNA Science Centre, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB T2N 4N1, Canada; Department of Chemistry, University of Calgary, Calgary, AB T2N 4N1, Canada.

Andrea Sinz (A)

Department of Pharmaceutical Chemistry & Bioanalytics, Charles Tanford Protein Center, Martin Luther University Halle-Wittenberg, Kurt-Mothes-Strasse 3a, 06120 Halle/Saale, Germany.

Frank Sobott (F)

School of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre for Structural and Molecular Biology, University of Leeds, Leeds LS2 9JT, UK; Department of Chemistry, Biomolecular and Analytical Mass Spectrometry Group, University of Antwerp, Groenenborgerlaan 171, 2020 Antwerp, Belgium.

Florian Stengel (F)

University of Konstanz, Department of Biology, Universitätsstrasse 10, 78457 Konstanz, Germany; Konstanz Research School Chemical Biology, University of Konstanz, Universitätsstrasse 10, 78457 Konstanz, Germany.

Konstantinos Thalassinos (K)

Institute of Structural and Molecular Biology, Birkbeck College, University of London, Malet Street, London WC1E 7HX, UK; Institute of Structural and Molecular Biology, Division of Biosciences, University College London, Gower Street, London WC1E 6BT, UK.

Henning Urlaub (H)

Bioanalytical Mass Spectrometry, Max Planck Institute for Biophysical Chemistry, Am Fassberg 11, 37077 Göttingen, Germany.

Rosa Viner (R)

Thermo Fisher Scientific, 355 River Oaks Parkway, San Jose CA 95134, USA.

Juan A Vizcaíno (JA)

European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK.

Marc R Wilkins (MR)

School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney 2052, Australia.

Juri Rappsilber (J)

Wellcome Centre for Cell Biology, School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3BF, Scotland, UK; Bioanalytics, Institute of Biotechnology, Technische Universität Berlin, 13355 Berlin, Germany. Electronic address: juri.rappsilber@tu-berlin.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH